- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/62 - Isoquinoline or hydrogenated isoquinoline ring systems
Patent holdings for IPC class C07F 9/62
Total number of patents in this class: 29
10-year publication summary
|
4
|
4
|
2
|
2
|
4
|
0
|
2
|
3
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4824 |
6 |
| Ardelyx, Inc. | 114 |
6 |
| Envista | 4 |
4 |
| Samsung Display Co., Ltd. | 36165 |
2 |
| Allergan, Inc. | 2315 |
2 |
| Exonhit Therapeutics SA | 24 |
2 |
| Canon Inc. | 41007 |
1 |
| Board of Regents, The University of Texas System | 5927 |
1 |
| Baylor College of Medicine | 972 |
1 |
| Nippon Chemical Industrial Co., Ltd. | 288 |
1 |
| Ormco Corporation | 234 |
1 |
| Opna Immuno-oncology SA | 1 |
1 |
| Opna Bio SA | 30 |
1 |
| Other owners | 0 |